Altium Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2M Buy
22,254
+4,381
+25% +$444K 0.14% 84
2022
Q1
$1.98M Buy
17,873
+5,950
+50% +$629K 0.13% 92
2021
Q4
$1.23M Sell
11,923
-1,217
-9% -$141K 0.08% 127
2021
Q3
$1.65M Buy
13,140
+319
+2% +$41.3K 0.12% 95
2021
Q2
$1.59M Buy
12,821
+244
+2% +$30.6K 0.12% 95
2021
Q1
$1.49M Sell
12,577
-511
-4% -$59.9K 0.12% 96
2020
Q4
$1.53M Buy
13,088
+1,480
+13% +$163K 0.14% 85
2020
Q3
$1.21M Sell
11,608
-383
-3% -$38.5K 0.13% 83
2020
Q2
$1.1M Sell
11,991
-215
-2% -$20.6K 0.12% 84
2020
Q1
$1.1M Buy
12,206
+703
+6% +$74.8K 0.15% 75
2019
Q4
$1.3M Buy
11,503
+1,023
+10% +$112K 0.16% 76
2019
Q3
$1.14M Buy
10,480
+1,740
+20% +$182K 0.15% 80
2019
Q2
$851K Sell
8,740
-543
-6% -$49.6K 0.12% 103
2019
Q1
$845K Buy
9,283
+98
+1% +$8.77K 0.13% 97
2018
Q4
$835K Buy
9,185
+2,408
+36% +$225K 0.16% 87
2018
Q3
$667K Buy
6,777
+2,455
+57% +$227K 0.13% 126
2018
Q2
$370K Buy
+4,322
New +$361K 0.1% 149

Other funds holding MDT

Altium Wealth Management's MDT Position: Q2 2022 in Review

Altium Wealth Management increased its Medtronic (MDT) stake by 25% in Q2 2022, buying an estimated $444K and bringing the position to 22,254 shares worth $2M. The position accounts for 0.14% of the portfolio, ranked #84.

Altium Wealth Management first reported a position in MDT in Q2 2018 and has held it in 17 quarters since. 2,021 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Altium Wealth Management held 22,254 shares of Medtronic worth $2M as of Q2 2022.
  • Altium Wealth Management bought 4,381 Medtronic shares in Q2 2022, an estimated $444K.
  • Medtronic made up 0.14% of Altium Wealth Management's portfolio in Q2 2022, its #84 holding.
  • Altium Wealth Management first reported a position in Medtronic in Q2 2018 and has held it in 17 quarters since.
  • 2,021 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.